Process and Manufacture
We have established a comprehensive quality management system in compliance with requirements applicable to and enforced by global competent authorities
Explore further
We are dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular diseases, and other serious unmet medical needs
We have established a comprehensive quality management system in compliance with requirements applicable to and enforced by global competent authorities
Explore further
百（bǎi）奧泰生（shēng）物（wù）製 藥 股份有限公（gōng）司（sī） ( 上交所（suǒ）代（dài） 碼 ： 688177) 是一家位（wèi）於中國（guó）廣州（zhōu），基於科學（xué）而 創 新的全球性生物製 藥 企 業 ，以（yǐ）下（xià） 簡 稱 “ 百奧泰 ” 或 “...
-->Guangzhou, China– June 2 , 2024 – Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical companydeveloping a pipeline of innovative therapies and biosesimilars, will present apost...
Bio-Theraand STADA h ave reached an exclusive commercialization and license agreement forBAT2506, a biosesimilar candidate to Simponi ® (golimumab) Bio-Thera will maintain responsibility fordevelopment,...
